ABC Arbitrage SA Buys Shares of 13,767 Colgate-Palmolive Company $CL

ABC Arbitrage SA acquired a new stake in shares of Colgate-Palmolive Company (NYSE:CL) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 13,767 shares of the company’s stock, valued at approximately $1,101,000.

Several other institutional investors also recently bought and sold shares of CL. Westside Investment Management Inc. increased its position in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares in the last quarter. Copia Wealth Management bought a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $29,000. Vermillion & White Wealth Management Group LLC boosted its stake in shares of Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares in the last quarter. Cloud Capital Management LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter valued at $30,000. Finally, MTM Investment Management LLC acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at $39,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CL. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Deutsche Bank Aktiengesellschaft increased their price objective on Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a report on Monday, February 2nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, January 21st. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Finally, Raymond James Financial lowered their target price on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research note on Monday, October 20th. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.47.

Insider Activity at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. This represents a 63.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. This trade represents a 53.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Up 1.5%

Shares of CL stock opened at $95.36 on Thursday. The stock has a market capitalization of $76.87 billion, a PE ratio of 36.40, a P/E/G ratio of 4.24 and a beta of 0.29. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27. The business has a 50-day moving average of $83.06 and a 200 day moving average of $81.73.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the prior year, the company earned $0.91 EPS. The business’s revenue was up 5.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.